logo
Primrose Capital Gains Strategic Regulatory Window in Abu Dhabi

Primrose Capital Gains Strategic Regulatory Window in Abu Dhabi

Arabian Posta day ago
Primrose Capital Management has obtained in‑principle approval from the Financial Services Regulatory Authority of Abu Dhabi Global Market, marking the inception of its journey toward a full Financial Services Permission. The clearance paves the way for the Singapore‑based quantitative trading firm to establish a regulated presence in the UAE's leading international financial centre, offering data‑driven investment products to regional institutional investors and family offices.
Approval from the FSRA is a key hurdle for asset managers seeking to operate within ADGM's regulated framework. For Primrose, this milestone enables the deployment of its machine‑learning‑powered strategies—including global futures, options and digital‑asset derivatives—targeted specifically at family offices and sovereign investors in the Gulf. The move aligns with the growing trend of Gulf capital allocated to systematically managed hedge‑fund structures.
Primrose's Chief Investment Officer, Linus Ong, underscored the importance of regulated access. He stated that the clarity of ADGM's technology‑oriented rulebook provides assurance as the firm scales its operations, maintaining robust governance and client protection. He described the IPA as 'an important vote of confidence' in Primrose's investment model and its team.
ADVERTISEMENT
The approval enables Primrose to deepen capital market linkages between Singapore—its headquarters—and Abu Dhabi. With Gulf family offices managing over US$500 billion, there is rising appetite for transparent, risk‑managed products. Primrose intends to launch MENA‑domiciled feeder funds in the latter half of 2025, providing local investors with direct access to its flagship Global Multi‑Strategy and Digital Options programmes.
As it progresses toward full FSP status, Primrose plans to recruit portfolio‑engineering and client‑coverage specialists to its Abu Dhabi office. The expansion supports ADGM's goal of scaling its fintech and asset‑management ecosystem, and complements Abu Dhabi's strategy to position itself as a regional hub for innovation in both traditional and digital assets.
ADGM has been actively promoting its jurisdiction as a forward‑looking centre. From adopting English common law to establishing a bespoke regulatory framework for digital asset intermediaries, the authority seeks to balance innovation with investor protection. The in‑principle nod to Primrose underscores the regulator's willingness to support quantitative and technology‑centric financial firms.
The IPA is not Primrose's first engagement with ADGM. Earlier approvals, such as VersiFi's clearance for digital‑asset trading, attest to the FSRA's evolving regulatory regime aimed at market integrity and security. Firms granted IPA are expected to meet stipulated conditions before earning full licences, ensuring measured market entry.
Primrose Capital, founded in 2023, combines expertise from established quantitative hedge funds with digital‑asset innovation. Its founders include seasoned professionals from WorldQuant, Systematica, QCP and BlueCrest. The firm utilises proprietary machine‑learning infrastructure and rigorous risk‑management frameworks to deliver consistent performance across market cycles.
The Singapore‑Abu Dhabi corridor reflects broader strategic cooperation in capital‑markets and fintech. Regulatory harmony and mutual recognition across jurisdictions empower firms like Primrose to tap multiple pools of investor capital. The IPA feature reinforces the nascent but growing pipeline of cross‑border asset‑management activity in the Middle East.
That said, Primrose's approval emerges amid intensifying competition. ADGM has recently granted IPAs to a number of digital‑asset and commodity trading firms, all vying to serve Gulf‑based institutional investors. These include entities such as VersiFi, underscoring ADGM's ambition to assemble a diversified financial‑technology cluster.
The road ahead will require Primrose to meet various conditions set by FSRA, ranging from governance protocols and risk‑management systems to client‑onboarding processes and capital adequacy. Close collaboration with ADGM is expected over the coming months. Once full FSP status is awarded, Primrose will be authorised to market its full suite of strategies and legally establish feeder‑fund vehicles.
For ADGM, facilitating the entry of technology‑first managers is central to its mission. Its regulatory architecture—as seen in previous licences granted—strives to balance innovation with investor safeguards. With IPAs converted to full permissions, ADGM stands to solidify its standing as a premier hub for fintech, digital assets and quantitative finance in the Middle East.
Primrose's timing is opportune. Market indicators suggest digital‑asset derivatives and quant‑trading strategies are gaining acceptance among Gulf investors seeking diversified returns and capital‑efficiency. By positioning itself early through regulated access, Primrose hopes to capture a segment of the growing systematically‑oriented asset‑management market.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bahrain Marina Development signs CBRE for premium project
Bahrain Marina Development signs CBRE for premium project

ME Construction

timean hour ago

  • ME Construction

Bahrain Marina Development signs CBRE for premium project

Bahrain Marina Development Company has appointed CBRE Bahrain to oversee the retail units within the project. CBRE Bahrain will develop a comprehensive leasing strategy that includes selecting the optimal mix of brands, planning the commercial area, and implementing occupancy strategies, said a statement. Spanning a 250,000sqm area, Bahrain Marina boasts 128 retail units across high-end retail outlets, international restaurants, and renowned cafes. The project also includes luxury residential facilities, a marine club, and a five-star hotel. Bahrain Marina is one of the new waterfronts in the capital that aims to transform the shopping, tourism, and entertainment landscape. Under the agreement, CBRE Bahrain will manage the day-to-day operations of commercial facilities and develop an innovative leasing plan. This plan will involve identifying tenant quality, creating a commercial distribution map, and ensuring a balanced mix of retail, hospitality, and complementary services. This appointment aligns with Bahrain Marina's objective to attract global partners, ensuring a shopping and entertainment experience that enhances the project's appeal as an integrated urban destination. The Bahrain Marina Development Company has emphasised that the appointment of CBRE Bahrain marks a significant step towards elevating the commercial value of the project's components, and laying the groundwork for a shopping experience in the Kingdom. Strategically located on the east coast of Manama, Bahrain Marina is a waterfront project that was developed with an investment of US $527mn.

XS.com leads as global sponsor at African FinTech Summit in Casablanca
XS.com leads as global sponsor at African FinTech Summit in Casablanca

Zawya

time2 hours ago

  • Zawya

XS.com leads as global sponsor at African FinTech Summit in Casablanca

the leading global multi-asset broker and fintech innovator, is proud to announce its role as the Global Sponsor of the upcoming African FinTech Summit by The Trading Show, scheduled for July 12-13, 2025, at the Hyatt Regency in Casablanca, Morocco. The event represents one of the most significant gatherings of fintech, trading, and financial innovation leaders across the MENA region and Africa. The African FinTech Summit will bring together top executives, entrepreneurs, investors, and regulators to explore emerging trends, technological advancements, and strategic opportunities shaping the future of finance on the continent. As the Global Sponsor, will play a key role in facilitating knowledge exchange, promoting collaboration, and supporting the growth of Africa's dynamic fintech ecosystem. Shadi Salloum, Regional Director for in the MENA Region, commented: " is excited to support the African FinTech Summit as a Global Sponsor. Africa and the MENA region are witnessing tremendous innovation and growth in financial technology, and we see vast potential for empowering traders and investors through advanced, transparent, and accessible platforms. Our participation underscores our commitment to driving digital transformation and financial inclusion across emerging markets." At the summit, will showcase its cutting-edge multi-asset trading solutions, institutional-grade infrastructure, and tailored services designed to meet the unique needs of traders and investors in the region. Attendees can expect exclusive product demonstrations, expert-led discussions on market dynamics, risk management strategies, and insights into the digital evolution of finance. Aicha Fadhel, Managing Director at The Trading Show Company, commented: 'The success of our first edition of African FinTech Summit, under the distinguished patronage of as Global Sponsor, exceeded all expectations. This second edition reinforces our commitment to Africa's financial ecosystem and Morocco's unique role as a continental gateway. We believe that - As the event's Global Sponsor - will bring its unique expertise to the event's attendees.' This sponsorship aligns with broader strategy to deepen its footprint in emerging markets, particularly in regions that are rapidly adopting fintech innovations. By leveraging its global expertise and local insights, aims to empower a new generation of financial professionals and entrepreneurs to navigate the complexities of global markets with confidence. Beyond showcasing technology, is committed to fostering an inclusive financial ecosystem that supports sustainable economic growth across Africa and the MENA region. Through partnerships, education, and innovation, is dedicated to helping create opportunities that drive financial literacy and investment accessibility. Company Review The XS Group (operating under brand name 'XS' or ' is a Global Multi-Asset Broker providing access to trade a wide range of financial products. Established in Australia in 2010, has grown into a global market leader in the FinTech, financial services and online trading industry with licences in various jurisdictions and offices in different locations around the globe. offers traders, institutional investors and brokers worldwide access to deep institutional liquidity and advanced trading technology, combined with an efficient user experience, high-quality relationship management and excellent customer support. Risk Warning: Our products are traded on margin and carry a high level of risk and it is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved.

BioSapien extends Pre-series A funding round to over $8mln - with new investment from Globivest
BioSapien extends Pre-series A funding round to over $8mln - with new investment from Globivest

Zawya

time2 hours ago

  • Zawya

BioSapien extends Pre-series A funding round to over $8mln - with new investment from Globivest

New world-class talent for BioSapien also revealed: technological, operational, and medical excellence to shape future of precision medicine Abu Dhabi, U.A.E – BioSapien (the 'Company'), the pioneering biotech company behind MediChip™, a revolutionary localized cancer treatment platform - announces a new extension to its pre-Series A funding round and the appointment of new talent across the business - including Joseph Borrello PhD as Chief Technology Officer, Sonia Ramamoorthy MD MBA FACS as Head of Medical Affairs, Agnes Westelinck PharmD as Head of Regulatory U.S., Dirk Richter MD FACS as Head of Regulatory U.A.E., David Briere PhD as Director of Pharmacology, and Jerry Webb BSc as Head of Quality. BioSapien is delighted to welcome Globivest as an investor in the pre-Series A funding round. Globivest is the first women-led, gender lens venture capital fund from the MENA region - and has expertise in Life Sciences. BioSapien's pre-Series A funding total is now over $8 million, with investors including Global Ventures - a leading VC firm in MENA; plus Golden Gate Ventures and Dara Holdings. Globivest's stated mission is to break the myth that opposes capital returns to impact-driven models. Championing the WHO's 'One Health' approach, it specializes in innovative and scalable early-stage startups that drive health, social, and environmental change - making BioSapien an ideal fit for its portfolio. BioSapien also announces the acquisition of world-class talent across all tiers of the Company – with 12 new appointments. In addition to the appointments listed above, other new talent includes Zhiyu Xia PhD as Senior Manufacturing Engineer, Gaurav Vij MBA as Business Officer, Nancy Sperling MS MS as the QC Lead, Nivedita Sivakumar PharmD MS as Documentation and Compliance Manager, Manny Valenza BA as Clinical Development Associate and Jared Rice BA as the Research and Operations Lead. Dr. Khatija Ali, CEO of BioSapien, said: 'Two of the greatest challenges for young, fast-growing companies are establishing a strong balance sheet and attracting high-quality talent. Therefore, I am delighted to announce an extension of BioSapien's pre-Series A funding round. As a female-led healthcare fund in the MENA region - and backed by EU pharma - we are proud to have Globivest as an investor and strategic partner. 'Similarly, it gives me great pleasure to welcome new, world-class colleagues across all tiers of the Company. A business is only as good as its people - so it is thrilling to be joined by such high-quality, diverse talent. Together, we will shape a future where precision medicine is both globally impactful and locally accessible.' Dr. Laura-Joy Boulos, Partner at Globivest, commented: 'At Globivest, we back companies that don't just promise innovation - they deliver transformative, science-backed solutions with the power to shift paradigms. BioSapien's MediChip™ platform is a breakthrough in localized cancer treatment - scalable, precise, and deeply aligned with our One Health mission. We're proud to support Dr. Khatija Ali and her team as they build the future of accessible precision medicine.' Further information Thoburns Johanna Lawson-Dick BioSapien@ About BioSapien BioSapien is a clinical-stage biotechnology company pioneering the future of localized drug delivery through its proprietary biodegradable 3D-printed delivery platform. Headquartered between the United States and the UAE, BioSapien's flagship technology, MediChip™, enables sustained, targeted release of chemotherapeutics directly at the tumor site—minimizing systemic toxicity and revolutionizing cancer care. The company is backed by global experts in oncology, materials science, and regulatory strategy, and is preparing for its first-in-human clinical trials. As part of the UAE's growing biotech ecosystem, BioSapien is aligned with the nation's vision to advance precision medicine, health innovation, and localized manufacturing capabilities. With a clear regulatory pathway, strong IP portfolio, and transformational applications beyond oncology - including infectious disease and post-operative care - BioSapien is positioned to become a cornerstone of the UAE's sovereign biotech ambitions. For more information, visit About Globivest Globivest is the first women-led, gender-lens impact investment fund from the MENA region, championing the WHO's One Health approach. The fund blends financial returns with meaningful, science-backed impact, investing in tech-driven, early-stage startups at the intersection of health, social, and environmental innovation. With a footprint across EMEA and the Americas, Globivest supports cross-border scale and market expansion. A key differentiator lies in Globivest's partnership with Sci-dip, a digital health platform founded by Globivest partner Dr. Laura-Joy Boulos, connecting the fund to a network of over 10,000 PhD experts. This collaboration enhances scientific due diligence and positions Globivest as a trusted co-investor for top-tier VC firms — particularly in life sciences, where depth of domain expertise is essential. Managing partner Jasmine Busson is a Kauffman Fellow, joining a global network of elite investors responsible for over $8.5T in exits. With Fund II now officially closed and a growing portfolio of nine companies, Globivest is emerging as a leading force in science-driven impact investing in the region.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store